HPC
VCYT icon

HM Payson & Co’s Veracyte VCYT Stock Holding History

HM Payson & Co’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-383
Closed -$21K – 1178
2021
Q1 		$21K Sell
383
-239
-38% -$13.8K ﹤0.01% 751
2020
Q4 		$30K Sell
622
-170
-21% -$7.88K ﹤0.01% 706
2020
Q3 		$26K Buy
+792
New +$25.2K ﹤0.01% 692

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HM Payson & Co's VCYT Position: Q2 2021 in Review

HM Payson & Co sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 383 shares — an estimated $21K sold.

HM Payson & Co first reported a position in VCYT in Q3 2020 and held it in 3 quarters. The position peaked at $30K in Q4 2020. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • HM Payson & Co reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • HM Payson & Co sold 383 Veracyte shares in Q2 2021, an estimated $21K.
  • HM Payson & Co first reported a position in Veracyte in Q3 2020 and held it in 3 quarters.
  • HM Payson & Co's Veracyte position peaked at $30K in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.